Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss differences among platforms for genetic profiling of metastatic non–small cell lung cancer in terms of sensitivity, specificity, and multiplex capability, as well as detection of complex genomic alterations.
10 hours ago
21 days ago
New data shows stem cell derived exosome platform provides a significant increase in delivery of siRNA compared to a conventional exosome approaches
October 10, 2022
August 11, 2022